SCHEMBL1534478

SCHEMBL1534478

O=c1c(I)c(-c2ccccc2)oc2cc(F)c(F)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.49
BACE1 P56817 2/20 0.49
BCHE P06276 2/20 0.49
KDM4E B2RXH2 6/20 0.44
CYP3A4 P08684 6/20 0.44
MAPT P10636 6/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
HSD17B10 Q99714 3/20 0.44
ADORA3 P0DMS8 3/20 0.44
ALOX15 P16050 2/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
ALDH1A1 P00352 4/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2C19 P33261 3/20 0.43
TSHR P16473 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CA12 O43570 2/20 0.42
ABCB1 P08183 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1534381 0.84 TNKS (0.55) ACHEBACE1BCHEKDM4ECYP3A4
SCHEMBL1534630 0.84 MAOB (0.55) ACHEBACE1BCHEKDM4ECYP3A4
SCHEMBL1423181 0.79 KMT2A (0.65) KDM4ECYP3A4MAPTMEN1KMT2A
SCHEMBL1534482 0.78 BCHE (0.46) ACHEBCHEKDM4ECYP3A4MAPT
SCHEMBL1534460 0.78 MEN1 (0.58) ACHEBACE1BCHEKDM4ECYP3A4
SCHEMBL1534705 0.78 BCHE (0.51) ACHEBCHEKDM4ECYP3A4MAPT
SCHEMBL1534555 0.78 GABRP (0.55) ACHEBCHEKDM4ECYP3A4MAPT
SCHEMBL30876960 0.78 MAPT (0.70) ACHEBCHEKDM4ECYP3A4MAPT
SCHEMBL1534379 0.77 AR (0.51) ACHEBCHEKDM4ECYP3A4MAPT
SCHEMBL1534426 0.76 ABCG2 (0.43) KDM4ECYP3A4MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546376-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2013-10-01 US disclosed
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2012-09-20 US disclosed
EP-2473495-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2012-07-11 EP disclosed
WO-2011033265-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2011-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS PIK3CA, PLK1, MTOR ACHE 1750/4885BACE1 1198/4885BCHE 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.